Andrew Kenwright

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Fabrizio De Benedetti, Hermine I. Brunner, Nicolino Ruperto et al. · New England Journal of Medicine · 2012 · 873 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +15

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber et al. · Annals of the Rheumatic Diseases · 2014 · 314 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis

Jianmei Wang, Adam Platt, Ruchi Upmanyu et al. · BMJ Open · 2013 · 62 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients

Essack Mitha, Gergely Kriván, Frédérique Jacobs et al. · Infectious Diseases and Therapy · 2019 · 26 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab

Janet Lee, Jianmei Wang, Mitchell Martin et al. · Pharmacogenetics and Genomics · 2011 · 25 citations

Life Sciences, Genetics, Molecular Genetics +16